Cervical cancer screening at crossroads (Q38232145)

31 August 2017

Cervical cancer screening at crossroads (English)

1 reference

31 August 2017

cervix uterine cancer

1 reference

7

Matejka Rebolj

0 references

Pierre-Antoine Dugué

4

object named as

Pierre-Antoine Dugué

0 references

Jesper Bonde

object named as

Jesper Bonde

6

0 references

Elsebeth Lynge

object named as

Elsebeth Lynge

1

0 references

author name string

Carsten Rygaard

2

1 reference

31 August 2017

Miguel Vazquez-Prada Baillet

3

1 reference

31 August 2017

Pierre-Antoine Dugué

4

1 reference

31 August 2017

Bente Braad Sander

5

1 reference

31 August 2017

1 August 2014

1 reference

Acta Pathologica et Microbiologica Scandinavica

31 August 2017

1 reference

31 August 2017

122

1 reference

31 August 2017

8

1 reference

31 August 2017

667-673

1 reference

A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions

31 August 2017

1 reference

Cervical cancer should be considered as a rare complication of oncogenic HPV infection rather than a STD.

21 January 2018

1 reference

Prevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay

21 January 2018

1 reference

Frequency of cervical intraepithelial neoplasia treatment in a well-screened population

21 January 2018

1 reference

Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period

21 January 2018

1 reference

Predictors of non-participation in cervical screening in Denmark.

21 January 2018

1 reference

Non-participation in screening: the case of cervical cancer in Denmark

21 January 2018

1 reference

Outcomes in cervical screening using various cytology technologies: what's age got to do with it?

21 January 2018

1 reference

Impact of technology on cytology outcome in cervical cancer screening of young and older women

21 January 2018

1 reference

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

21 January 2018

1 reference

Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay

21 January 2018

1 reference

Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening

21 January 2018

1 reference

Introduction of human papillomavirus vaccination in Nordic countries

21 January 2018

1 reference

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

21 January 2018

1 reference

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

21 January 2018

1 reference

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

21 January 2018

1 reference

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study

21 January 2018

1 reference

Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study

21 January 2018

1 reference

Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?

21 January 2018

1 reference

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)?

21 January 2018

1 reference

Increasing participation in cervical cancer screening: telephone contact with long-term non-attendees in Sweden. Results from RACOMIP, a randomized controlled trial.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APM.12279

1 reference

31 August 2017

1 reference